Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +9,636 $10.76 $104K 30,490
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +5,388 $11.10 $60K 35,878
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +12,123 $11.97 $145K 48,001
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +9,636 $17.76 $171K 57,637
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Sale 10b5-1 −14,027 $91.40 $1.3M 43,610
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Sale 10b5-1 −10,502 $92.03 $966K 33,108
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Sale 10b5-1 −12,034 $93.13 $1.1M 21,074
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Sale 10b5-1 −220 $94.01 $21K 20,854
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion · Share Option 10b5-1 −9,636 4,380
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion · Share Option 10b5-1 −5,388 0
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion · Share Option 10b5-1 −12,123 0
2026-11-02 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion · Share Option 10b5-1 −9,636 8,760
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion +2,694 18,848
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion +1,750 20,598
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion +1,591 22,189
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion +3,069 25,258
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Shares withheld for taxes −4,404 $79.28 $349K 20,854
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Grant or award · Restricted Share Unit +7,800 7,800
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Grant or award · Share Option +31,150 31,150
2026-09-01 Ragosa Mark CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Share Unit −3,069 9,206

Page 1 of 11 · 220 trades